Rapid Initiation of Drug Treatment Engagement (RIDE)
Rapid Initiation of Buprenorphine/Naloxone to Optimize MAT Utilization in Philadelphia
Sponsor: Philadelphia Department of Public Health
A PHASE4 clinical study on Opioid-use Disorder and Overdose, this trial is completed. The trial is conducted by Philadelphia Department of Public Health and has accumulated 16 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jul 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE4
▶ Show 11 earlier versions
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE4
-
Feb 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE4
-
May 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE4
-
Jan 2022 — May 2022 [monthly]
Active Not Recruiting PHASE4
-
Sep 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Active Not Recruiting → Recruiting
-
Apr 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Aug 2019 — Apr 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE4
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Philadelphia Department of Public Health
- Prevention Point Philadelphia
- Public Health Management Corporation
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .